Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in Tennessee compared to retail commercial list prices ($1250/mo).
Status: Tenn Comp R & Regs 1140-07
Tennessee permits licensed telehealth medical providers to prescribe verified compounded GLP-1 medications through certified 503A pharmacies.
Statutory Citation: TN Board of Pharmacy Compounding Standards
Tennessee permits licensed telehealth medical providers to prescribe verified compounded GLP-1 medications through certified 503A pharmacies.
Yes, under FDA 503A statutory guidance and Tennessee Board of Pharmacy rules, certified compounding pharmacies may dispense patient-specific formulations.
Average cash-pay clinical telehealth subscriptions in Tennessee average $295/month, compared to $1,250/month for retail commercial brands.
Yes. Tennessee permits synchronous telehealth physician evaluations and direct refrigerated shipping from licensed 503A facilities.
Explore statutory rules, state benchmarks, and customized calculation models across all 51 jurisdictions.
Browse deep clinical analysis and metabolic decision models on Groundwork.